SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Auro Laboratories informs about newspaper publications

31 May 2022 Evaluate

With reference to Regulation 47 of SEBI [Listing Obligations and Disclosure Requirements] Regulation, 2015 (Listing Regulations), Auro Laboratories has informed that it enclosed copies of Newspaper advertisement of Audited Financial Results of the Company for the quarter and year ended March 31, 2022, published in the following Newspapers: Mumbai Lakshdeep (i.e. Marathi newspaper) dated May 31, 2022; Active Times (i.e. English Newspaper) dated May 31, 2022. The results were taken on record by the Board of Directors in their meeting held on May 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Auro Laboratories Share Price

254.20 -2.70 (-1.05%)
05-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×